Back to Trades
King-Jones Heidy
See RemarksCIK 0001794898
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 1
- Active
- 2026
Across 3 filings between 2026, King-Jones Heidy, See Remarks, has disclosed $11.1M in transactions — all concentrated in Spyre Therapeutics, Inc. (SYRE). Their disclosed trades are heavily weighted toward selling — $0 in buys and $5.1M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Oct 2 | SYRE Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | Sell | $2.6M |
| Sep 3 | SYRE Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | Sell | $2.5M |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | Award | $4.3M |
3 filings